ABVC ABVC BioPharma, Inc. - Common Stock
NASDAQ · Biotechnology · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 12, 2026
$1,01
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$0,7152 haftanın en düşüğü
$3,4052 haftanın en yükseği
Piyasa Değeri (MRQ)
$26M
P/E
-2.6
Hisse Başına Kâr
$-0.39
rozetleriniz
52 Haftlık Aralık
$1–$3
Analist Derecelendirmesi
HOLD
Fiyat Hedefi
·
P/E
-2.6
ROE
-128.2%
Net Kâr Marjı
·
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
ABVC Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$1.01
Piyasa Değeri (MRQ)
$26M
P/E
-2.6
Hisse Başına Kâr
$-0.39
ROE
-128.2%
D/E Borç/Özsermaye (MRQ)
0.0
52 Haftlık Aralık
$1–$3
ABVC Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 25 Temmuz 2023 | 1-for-10 | Ters |
| 08 Mayıs 2019 | 1-for-18 | Ters |
| 11 Nisan 2016 | 157-for-50 | İleri |
| 13 Ağustos 2015 | 1-for-5000 | Ters |
| 18 Şubat 2011 | 1-for-5 | Ters |
| 19 Haziran 2007 | 1573-for-1000 | İleri |
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir·2019-12-31 → 2024-12-31
Hisse Başına Kâr$-0.392020-12-31 → 2025-12-31
Serbest Nakit Akışı·2022-12-31 → 2022-12-31
Net kar marjı·2019-12-31 → 2024-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | ABVC | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E | -2.6 | · | · | · | |
| P/S (F/S) | 48.3 | · | · | · | |
| F/D (MRQ) | 2.5 | · | 1.7 | Aşırı değerli | |
| EV / EBITDA | -3.5 | · | · | · | |
| Price / Cash Flow (Fiyat / Nakit Akışı) | -8.5 | · | · | · | |
| EV / Revenue (EV / Gelir) | 48.4 | · | · | · | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 2.3 | · | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | ABVC | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| ROA | -55.3% | · | -74.8% | En üst düzey | |
| ROE | -128.2% | · | -153.9% | En üst düzey | |
| ROIC | -60.4% | · | -77.4% | En üst düzey |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | ABVC | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Borç / Öz Sermaye (MRQ) | 0.0 | · | · | · | |
| Cari Oran (MRQ) | 0.1 | · | 2.0 | Düşük likidite | |
| Quick Ratio (Cari Oran) | 0.1 | · | 1.6 | Düşük likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | ABVC | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | 234.3% | · | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | 12.7% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-342.3%
Sonraki Rapor
Kas 02, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 31 Mart 2025 | $-0.06 | — | — | |
| 30 Haziran 2023 | $-0.68 | $-0.06 | -1011.1% | |
| 31 Mart 2023 | $-0.60 | $-0.51 | -17.6% | |
| 31 Aralık 2022 | $-1.50 | $-1.53 | 2.0% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | $509.6K | $152.4K | $969.8K | $355.8K | $483.0K | $701.7K | $7.0K | · | · | $3.4K | |
| Cost of Revenue | · | $763 | $302.0K | $286.4K | $5.1K | $18.7K | $20.1K | $185.3K | · | $32 | $521 | |
| Gross Profit | · | $508.8K | $-149.6K | $683.4K | $350.7K | $464.3K | $681.6K | $-178.3K | · | $-32 | $2.8K | |
| R&D Expense | $121.1K | $179.3K | $1M | $3M | $1M | $549.7K | $1M | $988.7K | $3M | $10M | · | |
| SG&A Expense | $3M | $2M | $5M | $6M | $6M | $4M | $3M | $2M | $811.7K | $599.3K | · | |
| Operating Expenses | $7M | $5M | $7M | $16M | $12M | $9M | $4M | $3M | $4M | · | $35.1K | |
| Operating Income | $-7M | $-5M | $-7M | $-15M | $-12M | $-9M | $-3M | $-3M | $-4M | $-11M | · | |
| Interest Expense | · | · | $1M | $294.0K | $227.2K | $405.0K | $482.0K | $462.8K | $103.5K | $10.2K | $0 | |
| Interest Income | $167.1K | $87.4K | $185.5K | $187.8K | $43.2K | $71.0K | $23.3K | $5.2K | $180 | $361 | · | |
| Other Non-op | $-13.6K | $134.4K | $3.4K | $-24.1K | $495.1K | $174.8K | $93.0K | $-5.2K | $-103.3K | $-9.7K | · | |
| Pretax Income | $-8M | $-5M | $-8M | $-16M | $-11M | $-11M | $-4M | $-6M | $-4M | $-11M | · | |
| Income Tax | $24.2K | $-110.5K | $256.0K | $797.8K | $825.0K | $-220.4K | $-77.0K | $-365.1K | $830 | $836 | · | |
| Net Income | $-8M | $-5M | $-8M | $-16M | $-13M | $-11M | $-4M | $-6M | $-4M | $-11M | $-32.3K | |
| EPS (Basic) | $-0.39 | $-0.42 | $-1.80 | $-5.19 | $-0.51 | $-0.50 | · | $-0.02 | $-0.02 | $-0.06 | · | |
| EPS (Diluted) | $-0.39 | $-0.42 | $-1.80 | $-5.19 | $-0.51 | $-0.50 | · | $-0.02 | $-0.02 | $-0.06 | · | |
| Shares (Basic) | 20,108,944 | 11,673,980 | 4,335,650 | 3,166,460 | 25,053,522 | 19,715,559 | · | 213,884,105 | 213,321,921 | 193,981,153 | 5,000,929 | |
| Shares (Diluted) | 20,108,944 | 11,673,980 | 4,335,650 | 3,166,460 | 25,053,522 | 19,715,559 | · | 213,884,105 | 213,321,921 | 193,981,153 | · | |
| EBITDA | $-7M | $-5M | · | $-15M | · | $-9M | $-3M | $-1M | · | · | · |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $681.5K | $248.4K | $60.2K | $85.3K | $6M | $4M | $144.3K | $226.7K | $350.3K | $173.5K | $994.8K | |
| Short-term Investments | $64.4K | $64.7K | $79.3K | $75.8K | $108.1K | · | · | · | · | · | · | |
| Receivables | · | · | $1.5K | $98.3K | $280.7K | $159.7K | · | · | · | · | · | |
| Inventory | · | · | · | · | $26.0K | · | · | $1.3K | · | · | $274 | |
| Prepaid Expense | $346.6K | $96.2K | $101.1K | $150.2K | $528.4K | $172.2K | $77.3K | $223.9K | · | · | · | |
| Current Assets | $3M | $2M | $2M | $3M | $8M | $6M | $878.2K | $566.5K | $3M | $173.5K | $998.6K | |
| PP&E (Net) | $13M | $511.1K | $569.3K | $574.0K | $525.9K | $514.8K | $520.9K | $510.1K | · | · | $0 | |
| PP&E (Gross) | $16M | $4M | $4M | $4M | $4M | $4M | $4M | $762.5K | · | · | · | |
| Accum. Depreciation | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $252.4K | · | · | · | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | $64.6K | |
| Other Non-current Assets | $117.0K | $133.1K | $141.2K | · | · | · | · | · | · | · | · | |
| Total Assets | $21M | $8M | $8M | $10M | $14M | $12M | $7M | $6M | $3M | $177.4K | $1M | |
| Accounts Payable | · | · | · | · | · | $23.0K | $24.0K | · | · | · | · | |
| Accrued Liabilities | · | · | $4M | $3M | $1M | $2M | · | · | · | · | $23.1K | |
| Short-term Debt | $755.5K | $840.3K | $899.2K | $2M | $2M | $2M | $2M | $899.2K | · | · | · | |
| Current Liabilities | $6M | $7M | $6M | $6M | $4M | $5M | $7M | $11M | $4M | · | $39.1K | |
| Capital Leases | $2M | $236.8K | $407.5K | $791.8K | $1M | $1M | $235.6K | · | · | · | · | |
| Total Liabilities | $8M | $7M | $7M | $6M | $5M | $9M | $7M | $11M | $4M | $7M | $369.1K | |
| Total Debt | $755.5K | $840.3K | · | $2M | · | $2M | $2M | · | · | · | · | |
| Common Stock | $25.1K | $13.9K | $7.9K | $3.3K | $28.9K | $24.4K | $19.5K | $11.9K | $213.7K | $210.8K | $3.1K | |
| Paid-in Capital | $96M | $79M | $74M | $68M | $58M | $41M | $28M | $15M | $14M | $5M | $1M | |
| Retained Earnings | $-77M | $-69M | $-64M | $-55M | $-38M | $-26M | $-16M | $-12M | $-16M | $-11M | $-315.6K | |
| Treasury Stock | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | · | · | · | |
| AOCI | $487.6K | $445.7K | $516.4K | $517.1K | $539.7K | $564.9K | · | · | · | · | · | |
| Stockholders' Equity | $11M | $1M | $2M | $3M | $9M | $3M | $-151.0K | $-6M | $-2M | $-6M | $633.4K | |
| Liabilities + Equity | $21M | $8M | $8M | $10M | $14M | $12M | $7M | $6M | $3M | $177.4K | $1M | |
| Shares Outstanding | 25,053,193 | 13,868,484 | 7,940,298 | 3,286,190 | 2,893,089 | 24,420,526 | 19,478,168 | 11,884,804 | 213,746,647 | 210,821,647 | 3,113,856 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | $23.8K | $12.0K | · | · | · | · | · | · | |
| Stock-based Comp | $4M | $3M | $185.9K | $7M | $5M | $4M | $22.3K | $28.8K | $155.4K | $398.0K | · | |
| Deferred Tax | · | · | $115.7K | $864.8K | $824.2K | $-223.2K | $-80.7K | $-366.9K | · | · | · | |
| Other Non-cash | · | · | · | $1M | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-3M | $-2M | $-4M | $-7M | $-8M | $-5M | $-3M | $-900.5K | $-1M | $-3M | $3.4K | |
| CapEx | · | · | $21.2K | $119.7K | $17.5K | · | · | · | · | · | · | |
| Investing Cash Flow | $-1M | · | $-360.2K | $-2M | $-806.0K | $-225.4K | $-35.3K | $-156.4K | · | · | $0 | |
| Debt Issued | · | · | · | · | $236.5K | · | · | · | · | · | · | |
| Stock Issued | · | · | $1M | $4M | $11M | $8M | · | · | · | $2M | · | |
| Net Stock Activity | · | · | · | $4M | · | $8M | $531.1K | · | · | · | · | |
| Financing Cash Flow | $5M | $2M | $4M | $4M | $10M | $10M | $3M | $896.9K | $2M | $3M | $0 | |
| Net Change in Cash | $463.2K | $147.0K | $-674.9K | $-5M | $2M | $5M | $-82.3K | $-164.1K | $74.7K | $-821.3K | $3.4K | |
| Taxes Paid | $12.1K | $25.9K | $27.4K | · | · | · | · | $1.9K | $830 | · | $0 | |
| Free Cash Flow | · | · | · | $-8M | · | · | · | · | · | · | · | |
| Levered FCF | · | · | · | $-8M | · | · | · | · | · | · | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | 99.9% | · | 70.5% | · | 96.1% | 97.1% | · | · | · | 84.5% | |
| Operating Margin | · | -923.3% | · | -1558.5% | · | -1760.9% | -492.9% | · | · | · | · | |
| Net Margin | · | -962.1% | · | -1693.5% | · | -2193.1% | -560.5% | · | · | · | -960.7% | |
| Pretax Margin | · | -1053.7% | · | -1599.8% | · | -2238.7% | -571.5% | · | · | · | · | |
| EBITDA Margin | · | -923.3% | · | -1556.1% | · | -1760.9% | -492.9% | · | · | · | · | |
| ROA | -55.3% | -64.0% | · | -139.5% | · | -114.3% | -61.1% | -299.4% | · | · | -48.3% | |
| ROE | -128.2% | -341.9% | · | -275.0% | · | -644.5% | 135.4% | 109.3% | · | · | -7.0% | |
| ROIC | -60.4% | -223.0% | · | -318.3% | · | -164.4% | -191.9% | 24.2% | · | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.4 | 0.3 | · | 0.5 | · | 1.3 | 0.1 | 0.0 | · | · | · | |
| Quick Ratio | 0.1 | 0.0 | · | 0.0 | · | 0.9 | 0.0 | 0.0 | · | · | · | |
| Debt / Equity | 0.1 | 0.7 | · | 0.6 | · | 0.5 | -12.7 | · | · | · | · | |
| Interest Coverage | · | · | · | -51.4 | · | -21.0 | -7.2 | -8.9 | · | · | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.1 | · | 0.1 | · | 0.1 | 0.1 | · | · | · | 0.1 | |
| Inventory Turnover | · | · | · | · | · | · | · | · | · | · | 1.0 | |
| Receivables Turnover | · | · | · | 5.1 | · | · | · | · | · | · | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.44 | $0.09 | · | $0.09 | · | $0.14 | $-0.01 | $-0.03 | · | · | $0.00 | |
| Revenue / Share | · | $0.04 | · | $0.03 | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-0.15 | $-0.15 | · | $-0.25 | · | · | · | $-0.00 | · | · | · | |
| Cash / Share | $0.03 | $0.02 | · | $0.00 | · | $0.17 | $0.01 | $0.00 | · | · | $0.00 | |
| EPS (TTM) | $-0.39 | $-0.42 | $-1.80 | $-5.19 | $-0.51 | $-0.50 | $-0.13 | $-0.02 | · | $-0.06 | · |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | 234.3% | -84.3% | 172.6% | -26.3% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | · | 12.7% | -31.9% | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $523.5K | $509.6K | $152.4K | $969.8K | $355.8K | $483.0K | $701.7K | $7.0K | · | · | $3.4K | |
| Net Income TTM | $-8M | $-5M | $-8M | $-16M | $-13M | $-11M | $-4M | $-6M | · | $-11M | $-32.3K | |
| Market Cap | $53M | $8M | · | $205M | · | $1.25B | $851M | $77.01B | · | · | $86.00B | |
| Enterprise Value | $53M | $9M | · | $207M | · | $1.24B | $853M | · | · | · | · | |
| P/E | -5.5 | -1.4 | -0.6 | -1.2 | -66.5 | -102.0 | -336.2 | -18000.0 | · | -6000.0 | · | |
| P/S | 101.9 | 16.1 | · | 211.8 | · | 2578.3 | 1213.0 | 11071525.4 | · | · | 25596199.6 | |
| P/B | 4.8 | 6.7 | · | 66.3 | · | 362.2 | -5638.4 | -13395.0 | · | · | 2957673.5 | |
| P / Tangible Book | 4.8 | 6.7 | 5.9 | 66.3 | 110.9 | 362.2 | · | · | · | · | · | |
| P / Cash Flow | -17.9 | -4.5 | · | -27.8 | · | -224.8 | -271.6 | -122205.9 | · | · | 25596199.6 | |
| P / FCF | · | · | · | -27.3 | · | · | · | · | · | · | · | |
| EV / EBITDA | -7.5 | -1.9 | · | -13.7 | · | -146.1 | -246.6 | · | · | · | · | |
| EV / FCF | · | · | · | -27.5 | · | · | · | · | · | · | · | |
| EV / Revenue | 102.0 | 17.1 | · | 213.5 | · | 2572.9 | 1215.5 | · | · | · | · | |
| Earnings Yield | -18.3% | -71.2% | -155.2% | -83.0% | -1.5% | -0.98% | -0.30% | -0.01% | · | -0.02% | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | $2.0K | $389.3K | $117.1K | $1.2K | $2.2K | $15.9K | $6.1K | $128.3K | $589.0K | $42.3K | |
| Cost of Revenue | · | · | · | · | · | · | $0 | $296 | $190 | $277 | $139.2K | $29.6K | $73.0K | $60.2K | $265.4K | $10.7K | |
| Gross Profit | · | · | · | · | · | · | $2.0K | $389.0K | $117.0K | $928 | $-137.0K | $-13.7K | $-66.9K | $68.0K | $323.6K | $31.5K | |
| R&D Expense | $22.7K | $33.1K | $29.1K | $29.9K | $33.3K | $28.9K | $32.0K | $37.8K | $40.4K | $69.1K | $72.2K | $141.3K | $514.4K | $335.0K | $1M | $305.5K | |
| SG&A Expense | $503.8K | $752.0K | $783.6K | $798.3K | $690.1K | $615.4K | $311.5K | $557.6K | $653.8K | $738.5K | $2M | $1M | $1M | $1M | $67.5K | $3M | |
| Operating Expenses | $779.5K | $2M | $2M | $2M | $2M | $693.0K | $706.5K | $691.3K | $977.1K | $3M | $374.8K | $2M | $2M | $2M | $3M | $4M | |
| Operating Income | $-779.5K | $-2M | $-2M | $-2M | $-2M | $-693.0K | $-704.6K | $-302.3K | $-860.1K | $-3M | $-511.8K | $-2M | $-2M | $-2M | $-3M | $-4M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $181.7K | $-76.4K | $1M | $114.8K | $56.7K | $134.5K | $126.5K | |
| Interest Income | $683 | $3.8K | $81.6K | $47.3K | $19.1K | $19.1K | $11.9K | $44.3K | $27.1K | $4.0K | $37.5K | $40.2K | $55.0K | $52.7K | $60.5K | $48.2K | |
| Other Non-op | $6.9K | $-1.3K | $-10.2K | $2.2K | $-7.2K | $1.5K | $88.9K | $-7.1K | $33.2K | $19.5K | $7.6K | $-10.8K | $3.5K | $3.1K | $-29.0K | $-56.5K | |
| Pretax Income | $-810.5K | $-2M | $-3M | $-2M | $-2M | $-944.2K | $-796.5K | $-487.1K | $-1M | $-3M | $-525.0K | $-3M | $-2M | $-2M | $-4M | $-4M | |
| Income Tax | · | · | $0 | $527 | $23.6K | · | $0 | $355 | $-110.9K | · | $175.3K | $-999 | $81.7K | · | $962.9K | $4.2K | |
| Net Income | $-736.9K | $-2M | $-3M | $-2M | $-2M | $-842.1K | $-731.6K | $-394.8K | $-942.3K | $-3M | $-331.6K | $-3M | $-2M | $-2M | $-5M | $-4M | |
| EPS (Basic) | $-0.03 | $-0.06 | $-0.11 | $-0.09 | $-0.13 | $-0.06 | $-0.02 | $-0.03 | $-0.08 | $-0.29 | $0.25 | $-0.82 | $-0.68 | $-0.55 | $-3.26 | $-1.14 | |
| EPS (Diluted) | $-0.03 | $-0.06 | $-0.11 | $-0.09 | $-0.13 | $-0.06 | $-0.02 | $-0.03 | $-0.08 | $-0.29 | $0.25 | $-0.82 | $-0.68 | $-0.55 | $-3.26 | $-1.14 | |
| Shares (Basic) | 26,058,884 | 25,448,516 | · | 23,256,590 | 17,386,536 | 14,968,232 | · | 12,405,261 | 11,321,277 | 9,736,150 | · | 4,055,345 | 3,308,740 | 3,307,577 | · | 3,257,912 | |
| Shares (Diluted) | 26,058,884 | 25,448,516 | · | 23,256,590 | 17,386,536 | 14,968,232 | · | 12,405,261 | 11,321,277 | 9,736,150 | · | 4,055,345 | 3,308,740 | 3,307,577 | · | 3,257,912 | |
| EBITDA | $-779.5K | $-2M | · | $-2M | $-2M | $-693.0K | · | $49.9K | $-976.6K | $-3M | · | $-2M | $-2M | $-2M | · | $-4M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $31.9K | $140.3K | $681.5K | $192.1K | $388.3K | $152.2K | $248.4K | $137.3K | $124.3K | $30.5K | $60.2K | $500.1K | $99.3K | $1M | $85.3K | $1M | |
| Short-term Investments | $62.4K | $62.2K | $64.4K | $65.2K | $65.2K | $65.1K | $64.7K | $70.8K | $75.7K | $75.9K | $79.3K | $68.5K | $76.8K | $78.0K | $75.8K | $77.6K | |
| Receivables | · | · | · | · | · | · | · | $1.5K | $1.5K | $1.5K | $1.5K | $1.5K | $12.4K | $124.1K | $98.3K | $47.7K | |
| Inventory | · | · | · | $11.5K | $11.5K | $11.5K | · | · | · | · | · | · | · | · | · | $20.5K | |
| Prepaid Expense | $151.6K | $250.0K | $346.6K | $447.3K | $195.0K | $96.4K | $96.2K | $91.3K | $100.8K | $159.6K | $101.1K | $143.1K | $148.0K | $347.9K | $150.2K | $287.2K | |
| Current Assets | $411.7K | $648.8K | $3M | $3M | $3M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | |
| PP&E (Net) | $13M | $13M | $13M | $13M | $8M | $8M | $511.1K | $8M | $8M | $8M | $569.3K | $8M | $564.3K | $571.6K | $574.0K | $566.8K | |
| PP&E (Gross) | $16M | $16M | $16M | $16M | $12M | $12M | $4M | $11M | $11M | $11M | $4M | $11M | $4M | $4M | $4M | $4M | |
| Accum. Depreciation | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Other Non-current Assets | $106.7K | $106.4K | $117.0K | $117.0K | $141.3K | $127.1K | $133.1K | · | · | · | $141.2K | · | · | · | · | · | |
| Total Assets | $19M | $20M | $21M | $21M | $16M | $15M | $8M | $14M | $15M | $14M | $8M | $17M | $9M | $11M | $10M | $10M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | · | $4M | $3M | $3M | $3M | $1M | |
| Short-term Debt | $59.5K | $88.7K | $755.5K | $809.1K | $872.0K | $801.4K | $840.3K | $866.2K | $847.0K | $860.8K | $899.2K | $852.5K | $882.8K | $902.0K | $2M | $2M | |
| Current Liabilities | $6M | $5M | $6M | $7M | $7M | $7M | $7M | $6M | $7M | $7M | $6M | $5M | $6M | $5M | $6M | $4M | |
| Capital Leases | $1M | $2M | $2M | $164.1K | $177.1K | $167.0K | $236.8K | $142.2K | $228.8K | $318.2K | $407.5K | $507.2K | $609.1K | $711.4K | $791.8K | $880.2K | |
| Total Liabilities | $7M | $7M | $8M | $7M | $7M | $7M | $7M | $6M | $7M | $7M | $7M | $8M | $10M | $9M | $6M | $5M | |
| Total Debt | $59.5K | $88.7K | · | $809.1K | $872.0K | $801.4K | · | $866.2K | $847.0K | $860.8K | · | $852.5K | $882.8K | $902.0K | · | $2M | |
| Common Stock | $26.2K | $25.8K | $25.1K | $24.2K | $19.5K | $15.4K | $13.9K | $12.7K | $12.1K | $10.7K | $7.9K | $4.8K | $3.3K | $33.1K | $3.3K | $32.6K | |
| Paid-in Capital | $98M | $97M | $96M | $94M | $86M | $84M | $79M | $87M | $87M | $86M | $74M | $81M | $68M | $68M | $68M | $66M | |
| Retained Earnings | $-79M | $-78M | $-77M | $-74M | $-72M | $-70M | $-69M | $-71M | $-70M | $-69M | $-64M | $-62M | $-59M | $-57M | $-55M | $-50M | |
| Treasury Stock | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | |
| AOCI | $498.2K | $499.6K | $487.6K | $487.0K | $483.8K | $444.2K | $445.7K | $461.3K | $435.9K | $233.3K | $516.4K | · | · | · | $517.1K | · | |
| Stockholders' Equity | $10M | $11M | $11M | $12M | $7M | $5M | $1M | $8M | $8M | $8M | $2M | $9M | $-379.3K | $2M | $3M | $6M | |
| Liabilities + Equity | $19M | $20M | $21M | $21M | $16M | $15M | $8M | $14M | $15M | $14M | $8M | $17M | $9M | $11M | $10M | $10M | |
| Shares Outstanding | 25,767,664 | 25,767,664 | 25,053,193 | 24,190,340 | 19,533,416 | 15,378,305 | 13,868,484 | 12,711,345 | 12,051,823 | 10,698,315 | 7,940,298 | 4,823,043 | 3,308,074 | 33,080,740 | 3,286,190 | 32,632,329 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | · | · | $7.5K | $7.0K | $6.5K | · | $6.5K | |
| Stock-based Comp | $253.0K | $787.4K | $1M | $1M | $2M | $48.8K | $363.1K | $95.9K | $282.9K | $2M | $-1M | $817.7K | $225.7K | $366.5K | $2M | $225.7K | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | $151.4K | $-117.4K | · | · | $896.0K | $138.9K | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | · | · | · | · | $319.6K | · | · | |
| Operating Cash Flow | $-244.4K | $-894.2K | $-587.6K | $-964.7K | $-894.2K | $-539.8K | $-702.1K | $380.2K | $-694.1K | $-955.8K | $-430.5K | $-1M | $-899.8K | $-1M | $-461.1K | $-513.7K | |
| CapEx | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $89 | $4.4K | |
| Investing Cash Flow | $-101.5K | $47.1K | $-29.7K | $-513.4K | · | · | · | $44.8K | · | · | $154.2K | $-73.8K | · | · | $-83.3K | $-2M | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $-1M | · | · | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $-253.5K | $253.5K | |
| Financing Cash Flow | $226.2K | $-342.2K | $1M | $1M | $2M | $428.8K | $335.8K | $100.2K | $1M | $924.1K | $38.4K | $2M | $-31.6K | $2M | $-253.5K | $603.5K | |
| Net Change in Cash | $-108.4K | $-1M | $473.1K | $-222.4K | $316.8K | $-104.2K | $93.9K | $27.1K | $83.8K | $-57.8K | $-404.2K | $378.7K | $-1M | $400.1K | $-578.4K | $-2M | |
| Taxes Paid | $-7.2K | $5.9K | $10.1K | $44 | · | · | $0 | $-83 | · | · | · | · | · | · | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | 99.9% | 99.8% | 77.0% | · | -86.4% | -1094.7% | 53.0% | · | 74.6% | |
| Operating Margin | · | · | · | · | · | · | · | 12.8% | -833.7% | -285841.5% | · | -13566.3% | -35911.6% | -1486.0% | · | -8790.9% | |
| Net Margin | · | · | · | · | · | · | · | -47.9% | -1086.5% | -326388.1% | · | -20885.9% | -37052.1% | -1421.7% | · | -8765.0% | |
| Pretax Margin | · | · | · | · | · | · | · | -34.4% | -1181.1% | -330375.0% | · | -21210.5% | -36561.3% | -1479.1% | · | -8924.5% | |
| EBITDA Margin | · | · | · | · | · | · | · | 12.8% | -833.7% | -285841.5% | · | -13519.4% | -35797.1% | -1481.0% | · | -8775.6% | |
| ROA | -4.1% | -9.0% | · | -11.5% | -14.6% | -5.7% | · | -1.2% | -10.6% | -31.2% | · | -24.5% | -19.6% | -16.0% | · | -32.5% | |
| ROE | -8.5% | -19.3% | · | -20.0% | -29.5% | -12.8% | · | -2.1% | -32.2% | -83.1% | · | -44.2% | -50.5% | -40.1% | · | -51.1% | |
| ROIC | · | · | · | -15.3% | -29.4% | · | · | 0.54% | -9.8% | · | · | -21.6% | -451.7% | · | · | -47.8% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.1 | 0.1 | · | 0.5 | 0.4 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.5 | 0.4 | 0.7 | · | 0.7 | |
| Quick Ratio | 0.0 | 0.0 | · | 0.0 | 0.1 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.0 | 0.3 | · | 0.4 | |
| Debt / Equity | 0.0 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | -2.3 | 0.5 | · | 0.3 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -5.0 | · | -1.8 | -19.1 | -33.6 | · | -29.4 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.3 | |
| Receivables Turnover | · | · | · | · | · | · | · | 254.5 | 16.9 | 0.0 | · | 0.6 | 0.0 | 0.6 | · | 0.2 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.40 | $0.42 | · | $0.50 | $0.36 | $0.35 | · | $0.66 | $0.69 | $0.73 | · | $1.89 | $-0.11 | $0.05 | · | $0.18 | |
| Revenue / Share | · | · | · | · | · | · | · | $0.03 | $0.01 | $0.00 | · | $0.00 | $0.00 | $0.00 | · | $0.00 | |
| Cash Flow / Share | · | $-0.04 | · | · | · | $-0.04 | · | · | · | $-0.05 | · | · | · | $-0.05 | · | · | |
| Cash / Share | $0.00 | $0.01 | · | $0.01 | $0.02 | $0.01 | · | $0.01 | $0.01 | $0.00 | · | $0.10 | $0.03 | $0.03 | · | $0.04 | |
| EPS (TTM) | $-0.29 | $-0.39 | · | $-0.30 | $-0.24 | $-0.19 | · | $-0.15 | $-0.94 | $-1.54 | · | $-5.31 | $-5.63 | $-5.54 | · | $-2.24 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $509.6K | $509.6K | · | $509.6K | $509.6K | $509.6K | · | $509.8K | $136.4K | $25.4K | · | $739.3K | $765.6K | $1M | · | $343.0K | |
| Net Income TTM | $-7M | $-9M | · | $-6M | $-4M | $-3M | · | $-5M | $-7M | $-9M | · | $-12M | $-13M | $-12M | · | $-19M | |
| Market Cap | $41M | $25M | · | $74M | $43M | $16M | · | $9M | $9M | $14M | · | $5M | $17M | $212M | · | $287M | |
| Enterprise Value | $41M | $25M | · | $74M | $44M | $17M | · | $9M | $10M | $15M | · | $5M | $18M | $211M | · | $288M | |
| P/E | -5.4 | -2.5 | · | -10.1 | -9.3 | -5.6 | · | -4.6 | -0.8 | -0.9 | · | -0.2 | -0.9 | -1.2 | · | -3.9 | |
| P/S | 79.9 | 49.0 | · | 144.3 | 85.3 | 32.0 | · | 17.0 | 68.4 | 552.6 | · | 6.8 | 22.5 | 197.4 | · | 837.2 | |
| P/B | 4.0 | 2.3 | · | 6.1 | 6.2 | 3.0 | · | 1.0 | 1.1 | 1.8 | · | 0.6 | -45.4 | 126.7 | · | 48.5 | |
| P / Tangible Book | 4.0 | 2.3 | · | 6.1 | 6.2 | 3.0 | · | 1.0 | 1.1 | 1.8 | · | 0.6 | · | 126.7 | · | 48.5 | |
| P / Cash Flow | · | -28.0 | · | · | · | -30.2 | · | · | · | -29.6 | · | · | · | -141.4 | · | · | |
| EV / Revenue | 79.8 | 48.8 | · | 145.4 | 86.1 | 33.1 | · | 18.3 | 73.1 | 582.3 | · | 7.2 | 23.4 | 197.1 | · | 838.6 | |
| Earnings Yield | -18.4% | -40.2% | · | -9.9% | -10.8% | -17.9% | · | -22.0% | -121.4% | -117.6% | · | -510.6% | -108.3% | -86.6% | · | -25.4% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|
| Gelir | · | $509.6K | · | · | · |
| Brüt Kâr Marjı % | · | 99.9% | · | · | · |
| Faaliyet Kâr Marjı % | · | -923.3% | · | · | · |
| Net Gelir | $-8M | $-5M | · | · | · |
| Seyreltilmiş Hisse Başı Kâr | $-0.39 | $-0.42 | · | · | · |
| Metrik | 2025-12-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | 0.1 | 0.7 | · | · | · |
| Cari Oran | 0.4 | 0.3 | · | · | · |
| Cari Oran | 0.1 | 0.0 | · | · | · |
Bu beyan için veri yok
Bu beyanı oluşturmak için henüz yeterli temel verisi yok.
Kurumsal Sahipler (13F) 17 dosya · $2.4M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
17
Tutulan Değer
$2.4M
Yeni pozisyonlar
8
Çıkan pozisyonlar
5
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 8 (+1 önceki Ç'ye göre) | 5 (-1 önceki Ç'ye göre) | 4 (+2 önceki Ç'ye göre) | 0 (-2 önceki Ç'ye göre) | +274K |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| VANGUARD GROUP INC | $613.306 | 287.937 | 26,06% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $591.708 | 374.499 | 25,14% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $360.380 | 228.042 | 15,31% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $153.834 | 97.363 | 6,54% | Hisse senetleri |
| STATE STREET CORP | $115.024 | 72.800 | 4,89% | Hisse senetleri |
| CITADEL ADVISORS LLC | $113.904 | 72.091 | 4,84% | Hisse senetleri |
| BlackRock, Inc. | $89.178 | 56.442 | 3,79% | Hisse senetleri |
| NORTHERN TRUST CORP | $76.856 | 48.643 | 3,27% | Hisse senetleri |
| XTX Topco Ltd | $76.276 | 48.276 | 3,24% | Hisse senetleri |
| PANAGORA ASSET MANAGEMENT INC | $57.958 | 36.682 | 2,46% | Hisse senetleri |
| UBS Group AG | $53.914 | 34.123 | 2,29% | Hisse senetleri |
| JANE STREET GROUP, LLC | $31.693 | 20.059 | 1,35% | Hisse senetleri |
| CITADEL ADVISORS LLC | $18.328 | 11.600 | 0,78% | Satım opsiyonu |
| CITIGROUP INC | $853 | 540 | 0,04% | Hisse senetleri |
| LifeSteps Financial, Inc. | $474 | 300 | 0,02% | Hisse senetleri |
| Caitong International Asset Management Co., Ltd | $9 | 6 | 0,00% | Hisse senetleri |
| ROYAL BANK OF CANADA | $0 | 17 | 0,00% | Hisse senetleri |
Aktivistler ve %5+ sahipler 6 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Eugene Jiang ×2 başvurular | 15 Temmuz 2025 | 0,00% | Değişiklik | · | SEC |
| Shuling Jiang | 12 Temmuz 2022 | · | İlk başvuru | Pasif yatırım | SEC |
| Bonner John | 30 Eylül 2011 | · | İlk başvuru | · | SEC |
| Fairmount Five, LLC | 22 Eylül 2011 | · | İlk başvuru | · | SEC |
| Equity 11, Ltd. ×18 başvurular | 19 Ocak 2010 | · | İlk başvuru | · | SEC |
| Stromback Richard Dean ###-##-#### | 08 Ekim 2009 | · | İlk başvuru | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 9 içeriden öğrenenler · 5 yöneticiler · 5 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Robert G Crockett | Chief Executive Officer | 11 Mayıs 2011 A | 1.000.000 | 0 | 0 | $0 |
| Frank Thomas Krotine | COO | 25 Mayıs 2011 A | 510.217 | 0 | 0 | $0 |
| Kevin Patrick Stolz | VP & Controller | 27 Ocak 2012 A | 6.250 | 0 | 0 | $0 |
| Sally Judith Ramsey | VP New Product Development | 11 Mayıs 2011 A | 3.000.000 | 0 | 0 | $0 |
| Daniel V Iannotti | VP, General Counsel & Secretar | 11 Mayıs 2011 A | 400.000 | 0 | 0 | $0 |
| James Juliano | Yönetim kurulu üyesi | 12 Ağustos 2010 A | · | 0 | 0 | $0 |
| J.B. Smith | Yönetim kurulu üyesi | 13 Ocak 2010 P | 16.585.538 | 0 | 0 | $0 |
| Joseph Nirta | Yönetim kurulu üyesi | 20 Ekim 2008 A | 10.000 | 0 | 0 | $0 |
| Richard Dean Stromback | Yönetim kurulu üyesi | 01 Mart 2007 P | 10.637.500 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 2 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
ABVC Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 6 analist
SAT
0 0,0%
Güçlü Al
0 0,0%
Al
3 50,0%
Tut
1 16,7%
Sat
2 33,3%
Güçlü Sat
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 12, 2026